1769P - High incidence of nausea during initial and repeated courses if intravenous chemotherapy in patients receiving guideline consistent antiemetic prophylaxis: A prospective, o... von Smit, T., Van Eeden, R.I., Rapoport, B.L.

Volltext

High incidence of nausea during initial and repeated courses if intravenous chemotherapy in patients receiving guideline consistent antiemetic prophylaxis: A prospective, observati... von Smit, T., Van Eeden, R.I., Rapoport, B.L.

Volltext

Immune related adverse events associated with ipilimumab and nivolumab von Rapoport, B., Van Eeden, R.I., Smit, T.

Volltext

Durable remissions associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center von Smit, T., Rapoport, B.L., Van Eeden, R.I.

Volltext

Experience of immune-related adverse events associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center von Rapoport, B.L., Smit, T., Van Eeden, R.I.

Volltext

Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes von Rapoport, B.L., Barnard-Tidy, J., Van Eeden, R.I., Smit, T., Nayler, S., Benn, C.

Volltext

Prognostic significance of neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small cell lung cancer von Rapoport, B.L., Vorobiof, D.A., Langenhoven, L., Hall, J.M., Van Eeden, R.I., Smit, T., Chan, S.W., Botha, M.C., Raats, J.I., De Necker, M., Duvenhage, H.

Volltext